Multinational pharmacoeconomic analysis of topical and oral therapies for onychomycosis

Journal of Dermatological Treatment

Volumn 8, Issue 4, 1997, Pages 229-235

  Einarson, T R ^a   Oh, P I ^b   Gupta, A K ^c,d   Shear, N H ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d NONE   (Canada)

Author keywords

Antifungal agents; Onychomycosis; Pharmacoeconomic analysis

Indexed keywords

AMOROLFINE; ANTIFUNGAL AGENT; CICLOPIROX; GRISEOFULVIN; ITRACONAZOLE; TERBINAFINE;

ARTICLE; CANADA; CLINICAL PRACTICE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; FRANCE; GERMANY; HEALTH CARE COST; HUMAN; ITALY; MAJOR CLINICAL STUDY; META ANALYSIS; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REIMBURSEMENT; SPAIN; STATISTICAL ANALYSIS; TOPICAL DRUG ADMINISTRATION; UNITED KINGDOM;

EID: 0031436971     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.3109/09546639709160527     Document Type: Article

References (72)

1. Andre J, Achten G, Onychomycosis. Int J Dermatol (1987) 26: 481-90.
2. Achten G, Wanet-Rouard J, Onychomycoses in the laboratory. Mykosen (1978) 21: 125-7.
3. Gupta AK et al, Onychomycosis unsuspected by the patient: prevalence in dermatologists' offices - a multicenter study of 2001 patients. Int J Dermatol (1997) in press.
4. Grigoriu D, Grigoriu A, Les onychomycoses. Rev Med Suisse Romande (1975) 95: 839-49.
5. Elewski BE, Charif MA, Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. Arch Dermatol (1997) 133: 1172-3.
6. Scher RK, Onychomycosis is more than a cosmetic problem. Br J Dermatol (1994) 130: 15
7. Gupta AK, Sauder DN, Shear NH, Antifungal agents: an overview. Part I. J Am Acad Dermatol (1994) 30: 677-98.
8. Anderson DW, Griseofulvin: biology and clinical usefulness: a review. Ann Allergy (1965) 23: 103-10.
9. Gupta AK, Shear NH, Sauder DN, New antifungal agents. Curr Opin Dermatol (1993) 2: 200-6
10. Janssen PAJ, Symoens JE, Hepatic reactions during ketoconazole treatment. Am J Med (1983) 74: 80-5.
11. Knight TE, Shikuma CY, Knight J, Ketoconazole-induced fulminant hepatitis necessitating liver transplantation. J Am Acad Dermatol (1991) 25: 398-400.
12. Gupta AK, Sauder DN, Shear NH, Antifungal agents: an overview. Part II J Am Acad Dermatol (1994) 30: 911-33.
13. Shear NH, Gupta AK, Terbinafine for the treatment of pedal onychomycosis: a foot closer to the promised land of cured nails? Arch Dermatol (1995) 131: 937-42.
14. Gupta AK et al, Itraconazole for the treatment of onychomycosis. an overview. Int J Dermatol (1997) in press.
15. Jue SG, Dawson GW, Brogden RN, Ciclopirox olamine 1% cream: a preliminary review of its antimicrobial activity and therapeutic use. Drugs (1985) 29: 330-41.
16. Zaug M, Bergstraesser M, Amorolfine in the treatment of onychomycoses and dermatomycoses (an overview). Clin Exp Dermatol (1992) 17: 61-70.
17. Einarson TR, Arikian SR, Shear NH, Pharmacoeconomic analysis of oral treatments for onychomycosis: a Canadian study. J Res Pharm Econ (1995) 6: 3-22.
18. Einarson TR, Arikian SR, Shear NH, Cost-effective analysis for onychomycosis therapy in Canada from a government perspective. Br J Dermatol (1994) 130: 32-4.
19. Arikian SR et al, A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. Br J Dermatol (1994) 130: 35-44.
20. Einarson TR, Arikian SR, Doyle JJ, Rank-order stability analysis (ROSA): testing pharmacoeconomic data. Med Decis Making (1995) 15: 367-72.
21. DerSimonian R, Laird NM, Meta-analysis in clinical trials. Control Clin Trials (1986) 7: 177-8.
22. Hargreves GK, The treatment of onychomycosis with griseofulvin. Br J Dermatol (1960) 72: 358-64.
23. Reiss F, Kornblee L, Solowey C, Survey of long-term therapeutic results with griseofulvin in superficial fungus infections in 111 patients. N Y State J Med (1961) 3631-9.
24. Robinson HM et al, Griseofulvin, clinical and experimental studies. Arch Dermatol (1960) 81: 66-80.
25. Russell B et al, Chronic ringworm infection of the skin and nails treated with griseofulvin. Lancet (1960) 1: 1140-7.
26. Dompmartin D et al, Onychomycosis and AIDS. Clinical and laboratory findings in 62 patients. Int J Dermatol (1990) 29: 337-9.
27. Ulbricht H, Wörz K, Therapy of onychomycosis due to moulds with ciclopirox nail lacquer. Mycoses (1994) 37: 97-100.
28. Hay RJ, Clayton YM, Moore MK, A comparison of tioconazole 28% nail solution versus bases as an adjunct to oral griseofulvin in patients with onychomycosis. Clin Exp Dermatol (1987) 12: 175-7
29. Hay RJ, Roberts DT, Doherty VR, The topical treatment of onychomycosis using a new combined urea/imidazole preparation. Clin Exp Dermatol (1988) 13: 164-7
30. Munro CS, Rees JL, Shuster S, The unexpectedly rapid response of fungal nail infection to short duration therapy. Acta Derm Venereol (Stockh) (1992) 72: 131-3.
31. Qadripur VSA, Horn G, Höhler T, Zur lokalwirksamkeit von ciclopiroxolamin bei nagelmykosen. Drug Res (1981) 31: 1369-72.
32. Dykes PJ, Thomas R, Finlay AY, Determination of terbinafine in nail samples during systemic treatment for onychomycoses. Br J Dermatol (1990) 123: 481-6.
33. Mensing H, Polak-Wyss A, Splanemann V, Determination of the subungual antifungal activity of amorolfine after 1 month's treatment in patients with onychomycosis: comparison of two nail lacquer formulations. Clin Exp Dermatol (1992) 17 (suppl 1): 29-32.
34. Pittrof F et al, Loceryl nail lacquer - realization of a new galenical approach to onychomycosis therapy. Clin Exp Dermatol (1992) 17 (suppl 1): 26-8.
35. Zaias N, Drachman P, A method for the determination of drug effectiveness in onychomycosis. J Am Acad Dermatol (1983) 9: 912-19
36. Allen BR et al, Oral terbinafine: effective in the treatment of chronic nail dermatophytosis. Br J Dermatol (1989) 121: 16.
37. Clayton YM, Clinical and mycological diagnostic aspects of onychomycoses and dermatomycoses. Clin Exp Dermatol (1992) 17: 37-40.
38. Evans EGV, Nail dermatophytosis: the nature and scale of the problem. J Dermatol Treat (1990) 1 (suppl 2): 47-8.
39. Roberts DT, Oral therapeutic agents in fungal nail disease. J Am Acad Dermatol (1994) 31: S78-S81.
40. Goodfield MID, Andrew L, Evans EGV, Short term treatment of dermatophyte onychomycosis with terbinafine. BMJ (1992) 304: 1151-4.
41. Goodfield MJD et al, Treatment of dermatophyte infection of the finger- and toe-nails with terbinafine (SF 86-327, Lamisil), an orally active fungicidal agent. Br J Dermatol (1989) 121: 753-7.
42. Rakoski T, Terbinafine and onychomycosis. Dermatologica (1990) 181: 174.
43. Data on file. Hoechst AG, Frankfurt, Germany.
44. Lauharanta J, Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly. Clin Exp Dermatol (1992) 17 (suppl 1): 41-3.
45. Reinel D, Clarke C, Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly. Clin Exp Dermatol (1992) 17 (suppl 1): 44-9.
46. Hay RJ, Mackie RM, Clayton YM, Tioconazole nail solution - an open study of its efficacy in onychomycosis. Clin Exp Dermatol (1985) 10: 111-15.
47. Arenas R, Fernandez G, Dominguez L, Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent. Int J Dermatol (1991) 30: 586-9.
48. Davies RR, Everall JD, Hamilton E, Mycological and clinical evaluation of griseofulvin for chronic onychomycosis. BMJ (1967) 3: 464-8.
49. Faergemann J et al, Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis. J Am Acad Dermatol (1995) 32: 750-3.
50. Goldfarb NJ, Sulzberger MB, Experiences in one hundred thirty-seven patients with oral griseofulvin. Arch Dermatol (1960) 81: 859-62.
51. Haneke E et al, Short-duration treatment of fingernail dermatophytosis: a randomized, double-blind study with terbinafine and griseofulvin. J Am Acad Dermatol (1995) 32: 72-7.
52. Hay RJ, Clayton YM, Griffiths WAD, A comparative double blind study of ketoconazole and griseofulvin in dermatophytosis. Br J Dermatol (1985) 112: 691-6.
53. Kaminsky A, Comparative effects of griseofulvin on onychomycosis and on psoriasis. Arch Dermatol (1960) 81: 240-2.
54. Korting HC et al, Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole. Antimicrob Agents Chemother (1993) 37: 2064-8.
55. Piepponen T et al, Efficacy and safety of itraconazole in the long-term treatment of onychomycosis. J Antimicrob Chemother (1992) 29: 195-205.
56. Stevenson CJ, Djavahiszwili N, Chronic ringworm of the nails: long-term treatment with griseofulvin. Lancet (1961) 1: 373-4.
57. Svejgaard E, Oral ketoconazole as an alternative to griseofulvin in recalcitrant dermatophyte infections and onychomycosis. Acta Derm Venereol (Stockh) (1985) 65: 143-9.
58. Walsoe I, Stangerup M, Svejgaard E, Itraconazole in onychomycosis: open and double-blind studies. Acta Derm Venereol (Stockh) (1990) 70: 137-40.
59. Williams DI, Griseofulvin and Trichophyton rubrum infections. Arch Dermatol (1960) 81: 769-71.
60. Arenas R, Domíguez-Cherit J, Open randomized comparison of itraconazole versus terbinafine in onychomycosis. Int J Dermatol (1995) 34: 138-43.
61. De Doncker P et al, Intermittent pulse therapy with itraconazole for the treatment of onychomycosis. Poster at the American Academy of Dermatology Meeting February 1995 New Orleans, 1995.
62. Hanifin JM, Tofte SJ, Itraconazole therapy for recalcitrant dermatophyte infections. J Am Acad Dermatol (1988) 18: 1077-80.
63. Hay RJ, Clayton YM, Treatment of chronic dermatophytosis and chronic oral candidosis with itraconazole. Rev Infect Dis (1987) 9: S114-S118.
64. Hay RJ et al, An evaluation of itraconazole in the management of onychomycosis. Br J Dermatol (1988) 119: 359-66.
65. Baudraz-Rosselet F et al, Treatment of onychomycosis with terbinafine. Br J Dermatol (1992) 126: 40-6.
66. Cribier B, Grosshans E, Efficacité et tolérance dela terbinafine (Lamisil) dans une série de 50 onychomycoses ä dermatophytes. Ann Dermatol Venereol (1994) 121: 15-20.
67. Goodfield MJD, Short-duration therapy with terbinafine for dermatophyte onychomycosis: a multicentre trial. Br J Dermatol (1992) 126: 33-5.
68. Van Der Schroeff JG et al, A randomized treatment duration-finding study of terbinafine in onychomycosis. Br J Dermatol (1992) 126: 36-9.
69. Zaias N, Management of onychomycosis with oral terbinafine. J Am Acad Dermatol (1990) 23: 810-12.
70. De Doncker P et al, Pulse therapy with one-week itraconazole monthly for three or four months in the treatment of onychomycosis. Cutis (1995) 56: 180-3.
71. De Doncker P et al, Antifungal pulse therapy for onychomycosis. Arch Dermatol (1996) 132: 34-41
72. Shear NH et al, Pharmacoeconomic analysis of topical treatments for tinea infections. Pharmacoeconomics (1995) 7: 251-67.